Industry

Halda Therapeutics acquired by Johnson & Johnson for $3.05 billion – the largest acquisition ever across any therapeutic area for a Phase 1 company Scorpion Therapeutics acquired by Eli Lilly for Up to $2.5 billion – one of the highest-value strategic transactions announced in early 2025 Vigil Neuroscience acquired by Sanofi for a $470 million … [Read more…]

Announces EPS-3903, an Oral, Once-Daily STAT6 Inhibitor Development Candidate with Rapid, Continuous and Complete (>90%) In Vivo pSTAT6 Suppression and Efficacy Comparable to Dupilumab in Asthma and Atopic Dermatitis Disease Models Announces EDP-978, an Oral, Once-Daily KIT Inhibitor Clinical Candidate with Plans to File an Investigational New Drug Application in Q1 2026 Reported Positive Topline … [Read more…]

Landmark gift completes $2.1M campaign, making LuskinOIC the only pediatric facility in downtown Los Angeles with on-site MRI LOS ANGELES–(BUSINESS WIRE)–#CommunityImpact–The Everychild Foundation has awarded Luskin Orthopaedic Institute for Children (LuskinOIC) a transformative $1 million grant to purchase the Institute’s first MRI unit—marking the first seven-figure foundation grant in the nonprofit’s 114-year history. This extraordinary … [Read more…]

Experienced healthcare executive brings deep leadership expertise advancing technology solutions that improve healthcare access and outcomes by uniting people, systems, and purpose. NEW YORK–(BUSINESS WIRE)–Unite Us, the nation’s trusted technology partner for integrating health and community-based care, today announced the appointment of Sean Burke as its new President. With a career dedicated to improving healthcare … [Read more…]

CVAUSA, the largest network of private cardiology groups in the U.S., plans to broadly adopt Flyrcado in line with its mission to deliver the highest quality cardiovascular care for patients. CVAUSA currently performs approximately 85,000 cardiac positron emission tomography (PET) procedures annually, highlighting the potential opportunity for Flyrcado as adoption grows. GE HealthCare remains committed … [Read more…]

LONDON & MUMBAI, India–(BUSINESS WIRE)–$LTIM #AI—LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, has announced its selection as a strategic partner by Convatec, a leading global medical products and technologies company, for the implementation of SAP’s Digital Core – S/4HANA. As part of this engagement, LTIMindtree will support Convatec to … [Read more…]

– New 733-square-meter office will allow Deciphera to strategically expand its operations and further advance its commercial reach in Europe – OSAKA, Japan & WALTHAM, Mass.–(BUSINESS WIRE)–Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the opening of a new 733-square-meter office in Zug, Switzerland, to accommodate the company’s … [Read more…]

LAS VEGAS–(BUSINESS WIRE)–The recently concluded SupplySide Global 2025 was hailed as “the best ever” by a senior dietary supplement expert, who highlighted bioavailability as the defining frontier for health supplements in 2026. As “high content” gives way to “high absorption,” CELFULL – a clinically driven anti-aging health brand – unveiled Celfavor NADH, a controlled-release microsphere … [Read more…]

CHICAGO–(BUSINESS WIRE)–GE HealthCare (Nasdaq: GEHC) management will present at the following upcoming investor conference. Jefferies Global Healthcare Conference in London, England – Tuesday, November 18, 2025 at 9:30 am GMT/4:30 am ET/3:30 am CT GE HealthCare’s CFO, Jay Saccaro, will discuss a variety of topics related to business strategy and growth opportunities. He will also … [Read more…]

IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today issued the following statement in response to the jury verdict announced in the U.S. District Court for the Central District of California, which confirmed the validity of Masimo Patent No. 10,433,776, found Apple infringed this patent, and awarded Masimo $634 million in damages: “We are pleased by this outcome, … [Read more…]